longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

ZeroStack

ZSTK

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.06, within the reasonable range, cheaper than 24.39% of the time in the past 1 years, and the industry ranks 5/14, the industry Median -0.21.

-0.0567xP/E
$4.15Stock price
$-73.16Earnings per share
-0.0567xP/E
Stock price$4.15Earnings per share$-73.16

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-0.07x
Typical range
-0.15x–-0.05x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
08162432

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x10x20x30x40x50x
P/E ratio
Name/Symbol
AHCOUSAdaptHealth
-3.54x145.14%$805.79M
AHGUSAkso Health
-22.02x--$411.19M
ACHUSAccendra Health
-0.27x89.03%$82.29M
COSMUSCosmos Health
-1.13x66.67%$27.55M
MEDSUSDataMeds AI
-0.21x--$18.59M
ZSTKUSZeroStack
-0.06x90.76%$10.09M
POMUSPomdoctor
-0.20x--$5.97M
ATPCUSAgape ATP
-2.03x--$2.30M
VRAXUSVirax Biolabs
-0.39x52.53%$1.98M
BIMIUSBIMI International Medical
----$6.98K

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.